Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2026
Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobin Receptor (PIGR)Brianna M Krusen, Phyllis A Gimotty, Greg Donahue, et al.
Cancer Research|September 7, 2007
Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancerCeline M Vachon, Thomas A Sellers, Erin E Carlson, et al.
Molecular Microbiology|December 3, 2020
Organization of peptidoglycan synthesis in nodes and separate rings at different stages of cell division of Streptococcus pneumoniaeAmilcar J Perez, Michael J Boersma, Kevin E Bruce, et al.
ACS Central Science|May 11, 2016
Biological Responses to Engineered Nanomaterials: Needs for the Next DecadeCatherine J Murphy, Ariane M Vartanian, Franz M Geiger, et al.
Plos One|February 19, 2026
Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancerKhalid Jazieh, Erin E Carlson, Zafar Siddiqui, et al.
Molecular Microbiology|August 8, 2014
Pbp2x localizes separately from Pbp2b and other peptidoglycan synthesis proteins during later stages of cell division of Streptococcus pneumoniae D39Ho-Ching T Tsui, Michael J Boersma, Stephen A Vella, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 28, 2023
Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-UpDaniela L Stan, Julian O Kim, Daniel J Schaid, et al.
Clinical Pharmacology and Therapeutics|May 28, 2021
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast CancerJunmei Cairns, Krishna R Kalari, James N Ingle, et al.
JCO Clinical Cancer Informatics|January 18, 2019
PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual PatientKrishna R Kalari, Jason P Sinnwell, Kevin J Thompson, et al.
Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
Pageof 13